VEII yields 400000.00% · JNJ yields 2.13%● Live data
📍 VEII pulled ahead of the other in Year 1
Combined, VEII + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VEII + JNJ for your $10,000?
Value Exchange International, Inc. provides customer-centric technology solutions to the retail industries in the People's Republic of China, Hong Kong, Malaysia, and the Philippines. The company offers credit and debit card processing services to multinational retailers. It also provides systems maintenance and related services, including software patches and software code revisions; installing, testing, and implementing of software; training of customer personnel for the use of software; and technical support for software systems. In addition, the company offers system installation and implementation services comprising project planning, system analysis and design, hardware and consumables selection advice and sales, and system hardware maintenance services; and systems development and integration services. Further, it engages in the software development; trading and servicing of computer hardware and software; IT service call-center activities; and marketing, sale, and maintenance of point of sale (POS) software under the edgePOS brand, as well as sale of third party POS software programs. The company was formerly known as Sino Payments, Inc. and changed its name to Value Exchange International, Inc. in December 2017. Value Exchange International, Inc. was incorporated in 2007 and is based in Sha Tin, Hong Kong.
Full VEII Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.